Kelly Lawrence W & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.7M Sell
47,785
-3,271
-6% -$762K 3.25% 9
2025
Q4
$10.6M Hold
51,056
2.57% 17
2025
Q3
$9.47M Sell
51,056
-5,233
-9% -$897K 2.29% 19
2025
Q2
$8.6M Sell
56,289
-2,657
-5% -$408K 2.25% 18
2025
Q1
$9.78M Sell
58,946
-175
-0.3% -$27.4K 2.37% 18
2024
Q4
$8.55M Sell
59,121
-3,232
-5% -$501K 1.99% 22
2024
Q3
$10.1M Sell
62,353
-231
-0.4% -$36.8K 2.28% 22
2024
Q2
$9.15M Sell
62,584
-3,223
-5% -$479K 2.09% 23
2024
Q1
$10.4M Sell
65,807
-2,758
-4% -$439K 2.37% 20
2023
Q4
$10.7M Sell
68,565
-2,020
-3% -$310K 2.58% 19
2023
Q3
$11M Sell
70,585
-234
-0.3% -$38.6K 2.95% 16
2023
Q2
$11.6M Sell
70,819
-1,258
-2% -$203K 3.01% 15
2023
Q1
$11.2M Sell
72,077
-556
-0.8% -$89.8K 3.03% 14
2022
Q4
$12.8M Sell
72,633
-7,431
-9% -$1.28M 3.66% 9
2022
Q3
$13.1M Sell
80,064
-645
-0.8% -$109K 3.65% 6
2022
Q2
$14.3M Sell
80,709
-594
-0.7% -$106K 3.93% 7
2022
Q1
$14.4M Buy
81,303
+70
+0.1% +$11.9K 3.08% 13
2021
Q4
$13.9M Sell
81,233
-833
-1% -$136K 2.75% 16
2021
Q3
$13.3M Buy
82,066
+70
+0.1% +$11.9K 2.8% 15
2021
Q2
$13.5M Buy
81,996
+455
+0.6% +$75.3K 2.91% 15
2021
Q1
$13.4M Buy
81,541
+27,868
+52% +$4.51M 3.17% 14
2020
Q4
$8.45M Sell
53,673
-29,628
-36% -$4.37M 3.34% 14
2020
Q3
$12.4M Sell
83,301
-41,883
-33% -$6.2M 3.69% 11
2020
Q2
$17.6M Sell
125,184
-417
-0.3% -$60.8K 3.64% 13
2020
Q1
$16.5M Sell
125,601
-10,350
-8% -$1.47M 4.01% 11
2019
Q4
$19.8M Sell
135,951
-595
-0.4% -$80.7K 3.11% 14
2019
Q3
$17.7M Sell
136,546
-590
-0.4% -$77.7K 2.95% 17
2019
Q2
$19.1M Buy
137,136
+685
+0.5% +$94.8K 3.26% 13
2019
Q1
$19.1M Sell
136,451
-1,280
-0.9% -$171K 3.44% 11
2018
Q4
$17.8M Sell
137,731
-4,364
-3% -$609K 3.84% 6
2018
Q3
$19.6M Buy
142,095
+1,610
+1% +$214K 3.23% 9
2018
Q2
$17M Buy
140,485
+175
+0.1% +$21.8K 3.14% 12
2018
Q1
$18M Sell
140,310
-680
-0.5% -$91.9K 3.4% 8
2017
Q4
$19.7M Buy
140,990
+9,942
+8% +$1.38M 3.62% 5
2017
Q3
$17M Sell
131,048
-1,037
-0.8% -$137K 3.25% 7
2017
Q2
$17.5M Sell
132,085
-1,790
-1% -$228K 3.46% 4
2017
Q1
$16.7M Buy
133,875
+110
+0.1% +$13.1K 3.44% 5
2016
Q4
$15.4M Buy
133,765
+272
+0.2% +$31.4K 3.42% 7
2016
Q3
$15.8M Sell
133,493
-617
-0.5% -$74.9K 3.38% 5
2016
Q2
$16.3M Buy
134,110
+385
+0.3% +$43.7K 3.76% 4
2016
Q1
$14.5M Buy
133,725
+40
+0% +$4.14K 3.63% 5
2015
Q4
$13.7M Sell
133,685
-350
-0.3% -$35.2K 3.11% 10
2015
Q3
$12.5M Sell
134,035
-250
-0.2% -$24.2K 2.9% 10
2015
Q2
$13.1M Buy
134,285
+586
+0.4% +$58.7K 2.61% 15
2015
Q1
$13.5M Sell
133,699
-1,975
-1% -$201K 2.9% 12
2014
Q4
$14.2M Buy
135,674
+1,078
+0.8% +$114K 2.96% 11
2014
Q3
$14.3M Sell
134,596
-1,092
-0.8% -$113K 3.05% 10
2014
Q2
$14.2M Buy
135,688
+32,200
+31% +$3.25M 3.03% 9
2014
Q1
$10.2M Buy
103,488
+520
+0.5% +$48.2K 2.33% 24
2013
Q4
$9.43M Sell
102,968
-710
-0.7% -$65.4K 2.1% 27
2013
Q3
$8.99M Buy
103,678
+325
+0.3% +$29.2K 2.13% 26
2013
Q2
$8.87M Buy
+103,353
New +$8.77M 2.25% 21

Other funds holding JNJ

Kelly Lawrence W & Associates's JNJ Position: Q1 2026 in Review

Kelly Lawrence W & Associates reduced its Johnson & Johnson (JNJ) stake by 6.4% in Q1 2026, selling an estimated $762K and leaving 47,785 shares worth $11.7M. The position accounts for 3.25% of the portfolio, ranked #9.

Kelly Lawrence W & Associates first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.8M in Q4 2019. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Kelly Lawrence W & Associates held 47,785 shares of Johnson & Johnson worth $11.7M as of Q1 2026.
  • Kelly Lawrence W & Associates sold 3,271 Johnson & Johnson shares in Q1 2026, an estimated $762K.
  • Johnson & Johnson made up 3.25% of Kelly Lawrence W & Associates's portfolio in Q1 2026, its #9 holding.
  • Kelly Lawrence W & Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Kelly Lawrence W & Associates's Johnson & Johnson position peaked at $19.8M in Q4 2019.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Kelly Lawrence W & Associates's 13F filing for Q1 2026, filed 15 May 2026.